John E. Kao - 08 Mar 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ALHC
Reported as of: 08 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Mar 2022, 16:21:38 UTC
Prior SEC filing: 24 Nov 2021
Next SEC filing: 01 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao

Key filing fact

John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 10 Mar 2022.

Key facts

This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Mar 2022, 16:21.

Change

Previous filing in this sequence was filed on 24 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Award

Transaction value: $0
Shares: +496,689
Change %: +160%
Price: $0.000000
Shares after: 807,719
Date: 08 Mar 2022
Ownership: Direct
Footnotes: F1

ALHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,565,391
Date: 08 Mar 2022
Ownership: See Footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALHC transaction Derivative

Options (Right to Buy)

Award

Transaction value: $0
Shares: +364,964
Change %
Price: $0.000000
Shares after: 364,964
Date: 08 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 364,964
Exercise price: $9.06
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents 496,689 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Footnote F2

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Footnote F3

Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.